Trial intelligence / Profile preview

Booster and Catch-up Vaccination with Synflorix in Children

NCT01030822Phase 3Completed

Sponsor
GSK
Start
Apr 2010
Primary completion
Aug 2011
Modality
Split/Subunit Vaccines
Countries
1
01

Overview

A Phase 3 trial of 10-valent pneumococcal conjugate vaccine in pneumococcal infection, sponsored by GSK. Started Apr 2010; status: completed.

02

Drugs

10-valent pneumococcal conjugate vaccine
03

Conditions

pneumococcal infection

Beyond the preview

Go deeper on NCT01030822.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01030822.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call